Vor Biopharma Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $27.6M | $75.9M | $48.5M |
| FY2021 | $26.3M | $242.6M | $119.8M |
| FY2022 | $48.8M | $299.4M | $57.7M |
| FY2023 | $47.4M | $198.1M | $31.4M |
| FY2024 | $46.2M | $142.9M | $81.9M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $27.6M | $75.9M | $48.5M |
| FY2021 | $26.3M | $242.6M | $119.8M |
| FY2022 | $48.8M | $299.4M | $57.7M |
| FY2023 | $47.4M | $198.1M | $31.4M |
| FY2024 | $46.2M | $142.9M | $81.9M |